Advertisement

Sample Acquisition and Test Requisition

  • Ross A. Miller
  • Ashwyna Sunassee
Chapter

Abstract

In the modern era of cytopathology, sample acquisition refers to the process of procuring specimen material for both cytopathologic examination and ancillary testing. Depending on the site, sample acquisition can be categorized as either exfoliative or aspiration which refers to how material is obtained. Fine-needle aspiration (FNA) is a type of aspiration specimen procurement used to target a specific area not amenable to exfoliative techniques. Mastery of the FNA technique is critical in order to obtain optimal material for cytopathologic examination and further testing. Often, rapid on-site evaluation (ROSE) is utilized in aspiration cytopathology which allows for on-site and real-time specimen adequacy evaluation and allows for appropriate specimen triage during the procedure. After specimen collection, an appropriate test requisition should accompany the specimen to the cytopathology laboratory. This ensures the correct sample is matched with the correct patient and that the sample is appropriately handled.

Keywords

Sample acquisition Fine-needle aspiration Rapid on-site evaluation Test requisition Ancillary testing 

Abbreviations

CNB

Core-needle biopsy

EBUS

Endobronchial ultrasound

EUS

Endoscopic ultrasound

FNA

Fine-needle aspiration

ROSE

Rapid on-site evaluation

References

  1. 1.
    Light RW. Useful tests on the pleural fluid in the management of patients with pleural effusions. Curr Opin Pulm Med. 1999;5:245–9.CrossRefGoogle Scholar
  2. 2.
    Friedman MA, Slater E. Malignant pleural effusions. Cancer Treat Rev. 1978;5:49–66.CrossRefGoogle Scholar
  3. 3.
    Meyers DG, Meyers RE, Prendergast TW. The usefulness of diagnostic tests on pericardial fluid. Chest. 1997;111:1213–21.CrossRefGoogle Scholar
  4. 4.
    Sahn SA. Plueral effusions in lung cancer. Clin Chest Med. 1982;3:443–52.PubMedGoogle Scholar
  5. 5.
    Ben-Horin S, Shinfeld A, Kachel E, et al. The composition of normal pericardial fluid and its implications for diagnosing pericardial effusions. Am J Med. 2005;118:636–40.CrossRefGoogle Scholar
  6. 6.
    Papanicolaou GN. New cancer diagnosis. In: Proceeding of the third race Betterment conference. 1928; p. 528–34.Google Scholar
  7. 7.
    Kreula J, Brondestaom S, Virkkunun P. Sample size in fine needle aspiration biopsy. Br J Surg. 1989;76(12):1270–2.CrossRefGoogle Scholar
  8. 8.
    Ly A. Fine-needle aspiration biopsy technique and specimen handling. In: Cibas ES, Ducatman BS, editors. Cytology: diagnostic principles and clinical correlates. 4th ed. Philadelphia: Elsevier Saunders; 2014. p. 221–32.Google Scholar
  9. 9.
    Pitman MB, Abele J, Ali SZ, et al. Techniques for thyroid FNA: a synopsis of the National Cancer Institute Thyroid fine-needle aspiration state of the science conference. Diagn Cytopathol. 2008;36(6):407–24.CrossRefGoogle Scholar
  10. 10.
    Guidelines of the Papanicolaou Society of Cytopathology for fine-needle aspiration procedure and reporting. The Papanicolaou society of cytopathology task force on standards of practice. Diagn Cytopathol. 1997;17(4):239–47.Google Scholar
  11. 11.
    Mair S, Dunbar F, Becker PJ, Du Plessis W. Fine needle cytology – is aspiration suction necessary? A study of 100 masses in various sites. Acta Cytol. 1989;33(6):809–13.PubMedGoogle Scholar
  12. 12.
    Kamal MM, Arjune DG, Kulkarni HR. Comparative study of fine needle aspiration and fine needle capillary sampling of thyroid lesions. Acta Cytol. 2002;46(1):30–4.CrossRefGoogle Scholar
  13. 13.
    Papanicolaou Society of Cytopathology. Optimal FNA techniques video series by Britt-Marie Ljung, M.D. http://www.papsociety.org/fna.html.
  14. 14.
    Sehgal IS, Dhooria S, Aggarwal AN, Agarwal R. Impact of rapid on-site cytological evaluation (ROSE) on the diagnostic yield of transbronchial needle aspiration during mediastinal lymph node sampling: systematic review and meta-analysis. Chest. 2018;153(4):929–38.CrossRefGoogle Scholar
  15. 15.
    Yarmus L, Van Der Kloot T, Lechtzin N, et al. A randomized prospective trial of the utility of rapid on-site evaluation of transbronchial needle aspiration. J Bronchol Intervent Pulmonol. 2011;18(2):121–7.CrossRefGoogle Scholar
  16. 16.
    Yasukufu K, Chiyo M, Sekine Y, Chhajed PN, Shibuya K, Iizasa T, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest. 2004;126:122–8.CrossRefGoogle Scholar
  17. 17.
    Joseph M, Jones T, Lutterbie Y, et al. Rapid on-site pathologic evaluation does not increase the efficacy of endobronchial ultrasonographic biopsy for mediastinal staging. Ann Thorac Surg. 2013;96:403–10. 10.CrossRefGoogle Scholar
  18. 18.
    Layfield LJ, Bentz JS, Gopez EV. Immediate on-site interpretation of fine-needle: aspiration smears: a cost and compensation analysis. Cancer. 2001;93(5):319–22.CrossRefGoogle Scholar
  19. 19.
    Schmidt RL, Walker BS, Cohen MB. When is rapid on-site evaluation cost-effective for fine-needle aspiration biopsy Schmitt F, ed. PLoS One. 2015;10(8):e0135466.CrossRefGoogle Scholar
  20. 20.
    Iglesias-Garcia J, Dominguez-Munoz JE, Abdulkader I, Larino-Noia J, Eugenyeva E, Lozano-Leon A, Forteza-Vila J. Influence of on-site cytopathology evaluation on the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of solid pancreatic masses. Am J Gastroenterol. 2011;106:1705–10.CrossRefGoogle Scholar
  21. 21.
    Eedes CR, Wang HH. Cost-effectiveness of immediate specimen adequacy assessment of thyroid fine-needle aspirations. Am J Clin Pathol. 2004;121(1):64–9.CrossRefGoogle Scholar
  22. 22.
    Miller RA, Wright AM, Satrum LS, Mody DR, Schwartz MR, Thrall MJ. Utilization, review and reimbursement of cytology services in endobronchial ultrasound-guided procedures: challenge and opportunity. JASC. 2016;5:139–44.Google Scholar
  23. 23.
    Thrall M, Pantanowitz L, Khalbuss W. Telecytology: clinical applications, current challenges, and future benefits. J Pathol Inform [serial online]. 2011;2:51.CrossRefGoogle Scholar
  24. 24.
    Khurana KK. Telecytology and its evolving role in cytopathology. Diagn Cytopathol. 2012;40:498–502.CrossRefGoogle Scholar
  25. 25.
    da Cunha Santos G, Ko HM, Saieg MA, Geddie WR. “The petals and thorns” of ROSE (rapid on-site evaluation). Cancer Cytopathol. 2013;121(1):4–8.CrossRefGoogle Scholar
  26. 26.
    Appelbaum L, Kane RA, Kruskal JB, et al. Focal hepatic lesions: US-guided biopsy–lessons from review of cytologic and pathologic examination results. Radiology. 2009;250:453–8.CrossRefGoogle Scholar
  27. 27.
    Liao WY, Jerng JS, Chen KY, et al. Value of imprint cytology for ultrasound-guided transthoracic core biopsy. Eur Respir J. 2004;24:905–9.CrossRefGoogle Scholar
  28. 28.
    Williams C, Ponten F, Moberg C, et al. A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol. 1999;155(5):1467–71.CrossRefGoogle Scholar
  29. 29.
    Chowdhuri SR, Chen H, Staerkel G, Stewart JM. Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies. Mod Pathol. 2017;30(4):499–508.CrossRefGoogle Scholar
  30. 30.
    Killian JK, Walker RL, Suuriniemi M, et al. Archival fine-needle aspiration cytopathology (FNAC) samples: untapped resource for clinical molecular profiling. J Mol Diagn. 2010;12(6):739–45.CrossRefGoogle Scholar
  31. 31.
    Gailey MP, Stence AA, Jensen CS, Ma D. Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue. Cancer Cytopathol. 2015;123(1):30–9.CrossRefGoogle Scholar
  32. 32.
    Rekhtman N, Kazi S, Yao J, et al. Depletion of core needle biopsy cellularity and DNA content as a result of vigorous touch preparations. Arch Pathol Lab Med. 2015;139(7):907–12.CrossRefGoogle Scholar
  33. 33.
    Tong LCB, Rudomina D, Rekhtman N, Lin O. Impact of touch preparations on core needle biopsies. Cancer Cytopathol. 2014;122(11):851–4.CrossRefGoogle Scholar
  34. 34.
    Cobb CJ. FNA or core needle biopsy? Why not both? CAP Today [serial online] 2007, p. 107.Google Scholar
  35. 35.
    Cibas ES, Ducatman BS. Cytology: diagnostic principles and clinical correlates. Philadelphia: Saunders/Elsevier; 2014.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Ross A. Miller
    • 1
  • Ashwyna Sunassee
    • 2
  1. 1.Memorial Pathology Consultants, P.AKingwoodUSA
  2. 2.Department of Pathology and Genomic MedicineHouston Methodist HospitalHoustonUSA

Personalised recommendations